TAG overview

Which topics – in terms of our corporate responsibility – are of particular significance to our long-term success? What expectations do our various stakeholders have of us? And in which areas do we contribute to a more sustainable development? In an effort to answer these questions, in 2018, we again conducted a materiality assessment, thereby fulfilling the requirements of the Global Reporting Initiative (GRI) and the German CSR Directive Implementation Act.

Realignment

To decide which topics to include in our report, we regularly conduct comprehensive materiality assessments. With our 2018 Corporate Responsibility (CR) Report, we took this process a step further: Looking at a broad range of issues, we considered the topics on which the business activities of our company have a material impact and, conversely, the impact these topics have on our business activities.

Materiality process

Materiality process (graphic)

Identifying our topics

We first assessed the topics from previous materiality assessments in terms of their relevance before comparing them against the United Nations Sustainable Development Goals to determine the impact they have on these goals. As a next step, we discerned which additional sector-specific issues to include.

Analyzing external expectations and requirements

For each of the identified issues, we evaluated various external factors and assessed the impact they have on our business. Such aspects include relevant regulations, our competitors, the financial market, new requirements of non-governmental organizations (NGOs) on the chemical and pharmaceutical industries, and our economic setting. In conducting this analysis, we drew on relevant legislation, NGO reports and .

Analyzing our own impacts

As well as analyzing external factors, we also evaluated our company’s contribution to sustainable development. For each of the topics identified, we reviewed the following:

  • the influence of the industries in which we operate
  • our own positioning as a company
  • the number of value chain steps affected
  • the importance for our worldwide sites

Results of the analysis

We identified 35 topics that are of significance to our CR strategy and reporting and weighted them according to their relevance. The results were then discussed, validated and adopted by our CR Committee.

The issues rated as material form the focus of this CR Report. Since our stakeholders also expect information and transparency from us regarding less significant issues, we also report on these, albeit in less detail.

Identifying topics for non-financial disclosure

The German CSR Directive Implementation Act obliges us to review the “double materiality” of topics according to Section 289 (3) of the German Commercial Code. The principle of double materiality requires companies to disclose non-financial information when the following two criteria are met: Firstly, the information is necessary to understand the company’s business performance, business results and financial situation. And secondly, the information makes it possible to understand how the company’s business activities affect non-financial aspects.

We have reviewed the double materiality of the topics identified. Those that fall within the scope of this definition are marked in the materiality matrix. The topics are linked to the respective chapters in this report.

Material topics

Material topics (graphic)
Close

Health for everyone

* Part of the non-financial report

Close

Ethical conduct

* Part of the non-financial report

Close

Technology

* Part of the non-financial report

  • Very high importance
  • High importance
  • Medium importance
  • Very high importance
  • High importance
  • Medium importance

Material issues in our value chain

The following table shows where our material issues fall within the value chain: upstream in our supply chain, in the course of our own activities, or downstream with our customers and patients. Moreover, we have listed the issues to show the breakdown of materiality by business sector and stakeholder group.

 

ACTIVITIES OF MERCK
Upstream activities
Healthcare
Life Science
Performance Materials
Downstream activities

Product safety and quality

Chemical product safety
0
X
X
X
X

Material for:

Customers, Merck family, Shareholders, Government agencies, NGOs, Commercial and business associates

Patient safety
0
X
0
0
X

Material for:

Merck family, Shareholders, Government agencies, NGOs, Health systems, Patients

Product-related crime (formerly Counterfeit products)
0
X
0
0
X

Material for:

Customers, Merck family, Shareholders, Federations and policy makers, Government agencies, NGOs, Commercial and business associates, Health systems, Patients

Transport and warehouse safety
X
0
X
X
X

Material for:

Customers, Government agencies, Suppliers, Commercial and business associates, Communities

Ethical conduct

Bioethics
0
X
X
0
X

Material for:

Customers, Federations and policy makers, Government agencies, NGOs, Media, Scientists

Clinical studies
X
X
0
0
X

Material for:

Merck family, Shareholders, Federations and policy makers, Government agencies, NGOs, Media, Suppliers, Scientists, Patients

Animal welfare
X
X
X
X
0

Material for:

Government agencies, NGOs, Media, Suppliers, Scientists

Good business practice

Compliance
X
X
X
X
X

Material for:

Employees, Merck family, Shareholders, Government agencies, NGOs, Suppliers, Commercial and business associates, Health systems, Competitors

Responsible marketing
0
X
X
X
X

Material for:

Customers, Federations and policy makers, Media, Commercial and business associates, Health systems, Patients

Community involvement
0
X
X
X
X

Material for:

Merck family, Employees, NGOs, Media, Communities

Interactions with health systems
0
X
0
0
X

Material for:

Federations and policy makers, Government agencies, NGOs, Health systems, Patients

Governance
X
X
X
X
X

Material for:

Employees, Employee representatives, Merck family, Shareholders, Government agencies, Suppliers, Commercial and business associates, Customers

Data protection
X
X
X
X
X

Material for:

Employees, Employee representatives, Suppliers, Commercial and business associates, Customers, Patients

Health for all

Access to health
0
X
X
0
X

Material for:

NGOs, Media, Commercial and business associates, Health systems, Patients

Prices of medicines
0
X
0
0
X

Material for:

Merck family, Shareholders, NGOs, Media, Commercial and business associates, Health systems, Patients

Health awareness
0
X
0
0
X

Material for:

NGOs, Media, Commercial and business associates, Health systems, Patients, Communities, Competitors

Supply chain standards

Supply chain standards
X
X
X
X
X

Material for:

Customers, Merck family, Shareholders, Federations and policy makers, NGOs, Media, Suppliers, Competitors

Human rights

Human rights
X
X
X
X
X

Material for:

Customers, Federations and policy makers, NGOs, Media, Suppliers, Communities, Employees

Sustainable products

Sustainable product design
0
0
X
X
X

Material for:

Customers, Scientists

Attractive employer

Diversity
0
X
X
X
0

Material for:

Employees, Employee representatives, Merck family, Media

Attracting and retaining employees
0
X
X
X
0

Material for:

Employees, Employee representatives, Merck family, Shareholders, Competitors

Employee development
0
X
X
X
0

Material for:

Employees, Employee representatives

Good leadership
0
X
X
X
0

Material for:

Employees, Employee representatives

Employee engagement
0
X
X
X
0

Material for:

Employees, Employee representatives

Health and safety
X
X
X
X
0

Material for:

Employees, Employee representatives, Government agencies

Work 4.0 (formerly Digitalization of the world of work)
0
X
X
X
0

Material for:

Employees, Employee representatives

Technology

Innovation and R&D
X
X
X
X
X

Material for:

Customers, Merck family, Shareholders, Scientists, Health systems, Patients

Digitalization
X
X
X
X
X

Material for:

Scientists, Commercial and business associates, Customers, Patients

Resource efficiency

Waste and recycling
0
X
X
X
X

Material for:

Government agencies, NGOs, Communities, Customers

Water management
0
X
X
X
X

Material for:

Government agencies, NGOs, Communities

Environmental protection

Energy efficiency and renewable energy
0
X
X
X
X

Material for:

Federations and policy makers, NGOs, Customers

Greenhouse gas emissions
X
X
X
X
X

Material for:

Customers, Federations and policy makers, Government agencies, NGOs, Media, Suppliers

Plant and process safety
0
X
X
X
0

Material for:

Employees, Shareholders, Merck family, Government agencies, Media

Biodiversity
0
X
X
X
0

Material for:

Federations and policy makers, Government agencies, NGOs

Emissions
0
X
X
X
0

Material for:

Federations and policy makers, Government agencies, NGOs

ESG ratings
ESG ratings are used to assess a company’s financial performance through factors that include aspects of environmental management, social issues and good governance.

Cookie Disclaimer

This website uses 'cookies' to give you the best, most relevant experience. Using this website means you’re OK with this. You can change which cookies are set at any time - and find out more about them in our cookie policy. Privacy Statement